Investing Ideas
/
Italian Pharmaceuticals & Biotech Sustainable Track Record

Italian Pharmaceuticals & Biotech Sustainable Track Record

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.

1 companies

Philogen

Market Cap: €1.0b

Philogen S.p.A., ein Biotechnologieunternehmen, entwickelt Medikamente für die Onkologie und chronische Entzündungskrankheiten.

PHIL

€25.00

-1.8%

11.1%